Tech Company Financing Transactions
NantCell Funding Round
On 12/29/2018, NantCell landed $30 million in funding from private investors.
Transaction Overview
Company Name
Announced On
12/29/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2040 E Mariposa Ave.
El Segundo, CA 90245
USA
El Segundo, CA 90245
USA
Phone
Website
Email Address
Overview
NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by developing molecularly targeted therapeutics, based on the proteomic profile of the patient's tumor, independent of the cancer's anatomical type.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 12/29/2018: NuoDB venture capital transaction
Next: 12/29/2018: iota Biosciences venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs